Literature DB >> 15256872

Clinical efficacy and compatibility of allogeneic avital tissue transplants sterilized with a peracetic acid/ethanol mixture.

Axel Pruss1, Carsten Perka, Petra Degenhardt, Ute Maronna, Karin Büttner-Janz, Bodo Paul, Klaus Müller, Christoph Klumpp, Johannes C Bruck, Rüdiger Von Versen.   

Abstract

In the course of the past 20 years a quantity of approximately 60,000 allogeneic avital tissue grafts sterilized with the peracetic acid-ethanol method (PES) were transplanted successfully. Based on a retrospective report of clinical experience of the years 1997-2001 on the overall scope of tissue grafts manufactured by the Tissue Banks of the University Hospital Charité and the German Institute for Cell and Tissue Replacement, the clinical efficacy and side effects of 18.3% (3.087/16.823) of all transplants were studied. Cancellous (1.601/3.087) and cortical (291/3.087) bone transplants as well as amnion (1.027/3.087) constituted the greatest part. In 91% of the examined patients (2.369/2.592) tissue integration ratios ranging from good up to very well could be observed. The transplant function of defect replacement or of a spacer respectively could be obtained for all types of tissue. The clinical effect caused by the transplant resulted in more than 99% of the transplants in primary integration or in the desired aim of the therapy (defect replacement, stabilization in case of palliative operations, etc.). In less than 1% (9/2.592) of cases a secondary healing occurred for cancellous bone transplantations or, revisional operations became necessary. In all cases severe side effects, in particular transmission of infectious diseases or transplant rejections, were not observed.

Entities:  

Year:  2002        PMID: 15256872     DOI: 10.1023/A:1024697515420

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  15 in total

1.  [Validation of an automatic test system for sterile testing of amniotic membranes].

Authors:  H Thomasen; K-P Steuhl; D Meller
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

Review 2.  Amniotic membrane in oral and maxillofacial surgery.

Authors:  Marco Rainer Kesting; Klaus-Dietrich Wolff; Christopher Philipp Nobis; Nils Hagen Rohleder
Journal:  Oral Maxillofac Surg       Date:  2012-12-16

Review 3.  [Bone banks : The state-of-the-art].

Authors:  A Pruß; U Kalus
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

4.  Patient satisfaction and clinical results 10 years after modified open thoracoplasty for pectus deformities.

Authors:  Julia Franziska Funk; Christian Gross; Richard Placzek
Journal:  Langenbecks Arch Surg       Date:  2011-07-16       Impact factor: 3.445

5.  [Consequence of European Directive 2004/23/EC for bone banks in Germany].

Authors:  A Pruss; H Knaepler; B-D Katthagen; L Frommelt
Journal:  Orthopade       Date:  2005-11       Impact factor: 1.087

6.  Allografts: expanding the surgeon's armamentarium.

Authors:  Jan Brune; Tu-Lan Vu-Han; Norus Ahmed; Volker Eras; Axel Pruß; Carsten Perka
Journal:  Cell Tissue Bank       Date:  2022-06-28       Impact factor: 1.522

7.  [Modified PemberSal osteotomy technique with lyophilized human allograft].

Authors:  C Druschel; K Heck; C Kraft; R Placzek
Journal:  Oper Orthop Traumatol       Date:  2016-09-14       Impact factor: 1.154

8.  Quantification of growth factors in allogenic bone grafts extracted with three different methods.

Authors:  B Wildemann; A Kadow-Romacker; A Pruss; N P Haas; G Schmidmaier
Journal:  Cell Tissue Bank       Date:  2006-10-25       Impact factor: 1.522

9.  Variant Purification of an Allogeneic Bone Block.

Authors:  Jonas Lorenz; Markus Schlee; Sarah Al-Maawi; Poju Chia; Robert A Sader; Shahram Ghanaati
Journal:  Acta Stomatol Croat       Date:  2017-06

Review 10.  Disinfection of human musculoskeletal allografts in tissue banking: a systematic review.

Authors:  J Mohr; M Germain; M Winters; S Fraser; A Duong; A Garibaldi; N Simunovic; D Alsop; D Dao; R Bessemer; O R Ayeni
Journal:  Cell Tissue Bank       Date:  2016-09-24       Impact factor: 1.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.